37.67 0.00 (0.00%)
After hours: 4:39PM EST
|Bid||32.85 x 800|
|Ask||37.87 x 800|
|Day's Range||36.02 - 38.07|
|52 Week Range||24.35 - 39.30|
|Beta (5Y Monthly)||1.57|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 05, 2020 - May 10, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||39.46|
Today we'll evaluate Colfax Corporation (NYSE:CFX) to determine whether it could have potential as an investment idea...
NEW YORK, NY / ACCESSWIRE / February 21, 2020 / Colfax Corp. (NYSE:CFX) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on February 21, 2020 at 8:00 AM Eastern ...
Colfax Corporation (CFX), a leading diversified technology company, today announced that it will issue a press release providing financial results for the fourth quarter of 2019 on the morning of Friday, February 21, 2020. The Company will hold a conference call to discuss these results beginning at 8:00 a.m. Eastern on that day, which will be open to the public through +1-877-303-7908 (U.S. callers) and +1-678-373-0875 and referencing the conference ID number 5553506 and through webcast via Colfax’s website www.colfaxcorp.com under the “Investors” section. Colfax’s financial results press release and supplemental information referenced on the call, if any, for the fourth quarter of 2019 will be available under the “Investors” section of Colfax’s website prior to the conference call.
Colfax (CFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Colfax Corporation (NYSE:CFX), which is in the machinery business, and is based in United States, received a lot of...
Portfolio Manager Lauren Romeo gives a comprehensive review of two key holdings in our Premier Quality Strategy Continue reading...
Colfax (CFX) is likely to gain from acquired assets, healthy medical technology business and emerging market exposure. High costs, forex woes and huge debts are concerns.
Matt Trerotola became the CEO of Colfax Corporation (NYSE:CFX) in 2015. This analysis aims first to contrast CEO...
Moody's Investors Service (Moody's) affirmed Colfax Corporation's (Colfax) corporate family rating at Ba2, the Probability of Default Rating at Ba2-PD and the senior unsecured ratings at Ba2. In addition, the Speculative Grade Liquidity rating was maintained at SGL-2. The rating actions also include Moody's expectations for the integration of DJO to continue progressing to plan as well as the anticipation that medical technology revenues will add resiliency to the top line while boosting margins and cash flow.
Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals. They generate significant returns for investors to justify their large fees and they allocate a lot of time and employ complex research processes to determine the best stocks to invest in. A particularly […]
Colfax (CFX) benefits from acquisitions, productivity actions and product developments. However, escalating costs and a highly leveraged balance sheet are headwinds.
Apogee's (APOG) Q3 performance likely to reflect benefits from solid bidding and order activities, robust backlog, and an upbeat North America commercial construction market.
Cintas' (CTAS) fiscal second-quarter earnings are likely to have gained from strong prospects in Uniform Rental and Facility Services and First Aid and Safety Services segments.
Colfax Corporation (CFX), a leading global manufacturer of medical technology and fabrication technology products and services, today announced that it has appointed Liam Kelly, President and CEO of Teleflex Incorporated, to its Board of Directors effective January 1, 2020. This appointment increases the size of Colfax's Board of Directors to ten members.
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November. Among them, Facebook and Microsoft ranked among the top 3 picks and these stocks gained 54% and 51% respectively. Hedge funds' top 3 stock picks returned 41.7% this year and beat […]
Annapolis Junction, MD, Dec. 02, 2019 -- Colfax Corporation (“Colfax”) (NYSE: CFX), a leading diversified technology company, today announced that it will host its annual.
Colfax (CFX) is likely to continue benefiting from acquisitions, productivity actions and product developments. However, a highly leveraged balance sheet remains a concern.
Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Granite Holdings US Acquisition Co. New York, November 14, 2019 -- Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Granite Holdings US Acquisition Co. and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers.
It is doubtless a positive to see that the Colfax Corporation (NYSE:CFX) share price has gained some 32% in the last...
Colfax Corporation (“Colfax”) (CFX), today announced that it will be presenting at Stifel’s 2019 Healthcare Conference in New York, NY, on November 20, 2019 at 2:25 pm EDT. A live presentation of this event will be available via Colfax’s website at www.colfaxcorp.com under the “Investors” section. ABOUT COLFAX CORPORATION — Colfax Corporation is a leading diversified technology company that provides orthopedic care and fabrication technology products and services to customers around the world principally under the DJO and ESAB brands.